Stephanie Reid

Stephanie Reid serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of scientific, technical, and operational capabilities. She manages a diverse portfolio of contracts focused on laboratory diagnostics, biomedical research, data analytics, and public health infrastructure, ensuring timely access to mission-critical services that enable disease surveillance, outbreak response, and epidemiological modeling. Her work directly supports CDC’s scientific and operational priorities by facilitating the acquisition of advanced testing platforms, clinical research support, and high-performance computing solutions essential to national health security. Reid maintains established working relationships with leading providers in the public health and life sciences sectors, including General Dynamics Information Technology, Cepheid, MRIGLOBAL, GlaxoSmithKline, and the New York City Health & Hospitals Corporation. These partnerships reflect a preference for proven, high-capacity vendors capable of delivering complex, regulated, and time-sensitive solutions—particularly in diagnostics, biosafety, and data systems. Her contracting approach emphasizes performance-based outcomes, compliance with federal biosafety standards, and scalability to meet surge capacity demands during public health emergencies. Reid’s procurement portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on technical capability and operational readiness over socioeconomic classifications, prioritizing the most qualified entities regardless of business size or certification status. While small business participation is not formally incentivized through set-asides, vendor diversity is maintained through open solicitation practices that encourage broad industry engagement. Her primary procurement focus lies in NAICS 541715 (R&D in life sciences), 541380 (testing laboratories), 541511 (custom computer programming), 541690 (scientific consulting), and 611310 (higher education institutions). These categories underscore her expertise in acquiring advanced diagnostic systems, bioinformatics platforms, clinical trial support, and public health data analytics services from academic, commercial, and nonprofit research partners.